Patents by Inventor Michael Mersmann

Michael Mersmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE THERAPEUTICS THAT BIND VEGF AND METHODS OF USE THEREOF
    Publication number: 20100093624
    Abstract: The present invention provides peptides and mimetics thereof that bind to VEGF. In preferred embodiments, the peptides of the invention are D type optical isomers which can bind VEGF and which can inhibit or reduce VEGF biological activity.
    Type: Application
    Filed: July 30, 2009
    Publication date: April 15, 2010
    Applicant: Cosmix Therapeutics LLC
    Inventors: Don LOW, Andreas Jungbluth, Gregor Schuermann, Michael Mersmann, Tamas Blandl, Katherine E. Hoover, Eberhard Schneider, Ying Hu, Peter Wagner
  • Human FAP-alpha-specific antibodies
    Publication number: 20020099180
    Abstract: The invention relates to antibody proteins which specifically bind fibroblast activating protein alpha (FAP&agr;). The invention further relates to the use of said antibodies for diagnostic and therapeutic purposes as well as processes for preparing said antibodies.
    Type: Application
    Filed: March 19, 2001
    Publication date: July 25, 2002
    Inventors: Klaus Pfizenmaier, Dieter Moosmayer, Michael Mersmann, Alexej Schmidt, John-Edward Park, Pilar Garin-Chesa